Adipocyte-specific deletion of PPARγ under the AdipoQ gene promoter leads to a nearly complete lack of AT, insulin resistance and massive liver steatosis, i.e. generalized lipodystrophy (83). The gene discussed is INS; the disease is fatty liver disease.